ArticleThe Annals of pharmacotherapy2023
Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.
Nancy Kierstin Reid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it